Vicarious Surgical
RBOT
RBOT was delisted on the 2nd of March, 2026.
79 hedge funds and large institutions have $87.1M invested in Vicarious Surgical in 2022 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 33 increasing their positions, 10 reducing their positions, and 13 closing their positions.
230% more repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 10
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
23% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 13
4% more funds holding
Funds holding: 76 → 79 (+3)
0.11% more ownership
Funds ownership: 1.29% → 1.4% (+0.11%)
34% less capital invested
Capital invested by funds: $133M → $87.1M (-$45.5M)
94% less call options, than puts
Call options by funds: $25K | Put options by funds: $404K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MAMHA
MY.Alpha Management HK Advisors
Hong Kong
|
+$9.45M |
| 2 |
DP
DDD Partners
Bellevue,
Washington
|
+$2.66M |
| 3 |
Jane Street
New York
|
+$1.61M |
| 4 |
Millennium Management
New York
|
+$953K |
| 5 |
Morgan Stanley
New York
|
+$526K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VIA
Vident Investment Advisory
Alpharetta,
Georgia
|
-$3.67M |
| 2 |
Legal & General Group
London,
United Kingdom
|
-$2.33M |
| 3 |
Skandinaviska Enskilda Banken (SEB)
Stockholm,
Sweden
|
-$502K |
| 4 |
Mirae Asset Global Investments
Seoul,
South Korea
|
-$141K |
| 5 |
AIM
Acropolis Investment Management
St. Louis,
Missouri
|
-$101K |
RBOT Hedge Fund Activity: Q4 2022 in Review
79 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Vicarious Surgical (RBOT) for Q4 2022, worth a combined $87.1M — down 34% from $133M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new RBOT positions and 13 closed out — a net gain of 3 holders — while 33 added to existing stakes and 10 trimmed.
The largest buyer was MY.Alpha Management HK Advisors, opening a new position worth an estimated $9.45M. The largest seller was Vident Investment Advisory, exiting entirely with an estimated $3.67M sold.
- 79 institutional investors held Vicarious Surgical (RBOT) as of Q4 2022, up from 76 in Q3 2022.
- Funds reported $87.1M of Vicarious Surgical stock for Q4 2022, down 34% quarter-over-quarter.
- 16 funds opened new Vicarious Surgical positions in Q4 2022 and 13 closed out, a net change of +3 holders.
- The largest Vicarious Surgical buyer in Q4 2022 was MY.Alpha Management HK Advisors, an estimated $9.45M added.
- The largest Vicarious Surgical seller in Q4 2022 was Vident Investment Advisory, an estimated $3.67M sold.
Based on aggregated 13F filings for Q4 2022.